{ "company_number": "04371441", "name": "Nanopharm Limited", "url": "/company/04371441", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2002-02-11", "dissolved_on": null, "sic_codes": [ { "code": "21200", "description": "Manufacture of pharmaceutical preparations", "section": "C", "section_name": "Manufacturing", "url": "/sic/21200" } ], "registered_address": { "id": 2027795, "url": "/address/2027795", "line1": "5 BRUNTCLIFFE AVENUE", "line2": "MORLEY", "post_town": "LEEDS", "county": "", "country": "ENGLAND", "postcode": "LS27 0LL" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04371441", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-12-31", "last_made_up": "2024-12-31", "category": "MEDIUM", "filings": [ { "url": "/company/04371441/accounts/2024-12-31", "pdf_url": "/company/04371441/accounts/2024-12-31.pdf", "made_up_date": "2024-12-31", "period_start": "2024-01-01", "period_end": "2024-12-31", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": "74.00", "tangible_fixed_assets": "4153089.00", "debtors": "3592729.00", "cash_bank_in_hand": "246713.00", "current_assets": "3839442.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-1671132.00", "total_assets_less_current_liabilities": "2481957.00", "net_assets_liabilities": "1765400.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": "8528227.00", "other_operating_income": null, "cost_sales": "7843716.00", "gross_profit_loss": "684511.00", "administrative_expenses": "3905189.00", "raw_materials_consumables": null, "staff_costs": "4279130.00", "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "-2633361.00", "profit_before_tax": "-2757798.00", "tax_on_profit": "498500.00", "profit_loss_for_period": "-3256298.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2025.zip" }, { "url": "/company/04371441/accounts/2023-12-31", "pdf_url": "/company/04371441/accounts/2023-12-31.pdf", "made_up_date": "2023-12-31", "period_start": "2023-01-01", "period_end": "2023-12-31", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": "59.00", "tangible_fixed_assets": "4424108.00", "debtors": "3162523.00", "cash_bank_in_hand": "54224.00", "current_assets": "3216747.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "815647.00", "total_assets_less_current_liabilities": "5239755.00", "net_assets_liabilities": "5021698.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": "7486864.00", "other_operating_income": null, "cost_sales": "5302236.00", "gross_profit_loss": "2184628.00", "administrative_expenses": "3457044.00", "raw_materials_consumables": null, "staff_costs": "3674654.00", "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "-919654.00", "profit_before_tax": "-893790.00", "tax_on_profit": "-182170.00", "profit_loss_for_period": "-711620.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2024.zip" }, { "url": "/company/04371441/accounts/2021-12-31", "pdf_url": "/company/04371441/accounts/2021-12-31.pdf", "made_up_date": "2021-12-31", "period_start": "2021-01-01", "period_end": "2021-12-31", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": "39.00", "tangible_fixed_assets": "2363121.00", "debtors": "2787270.00", "cash_bank_in_hand": "1339469.00", "current_assets": "4126739.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3566131.00", "total_assets_less_current_liabilities": "5929252.00", "net_assets_liabilities": "5643769.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "345579.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2022.zip" }, { "url": "/company/04371441/accounts/2020-12-31", "pdf_url": "/company/04371441/accounts/2020-12-31.pdf", "made_up_date": "2020-12-31", "period_start": "2020-01-01", "period_end": "2020-12-31", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": "36.00", "tangible_fixed_assets": "1081346.00", "debtors": "2351420.00", "cash_bank_in_hand": "1799729.00", "current_assets": "4151149.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3685542.00", "total_assets_less_current_liabilities": "4766888.00", "net_assets_liabilities": "4635690.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-2109234.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2021.zip" }, { "url": "/company/04371441/accounts/2019-12-31", "pdf_url": "/company/04371441/accounts/2019-12-31.pdf", "made_up_date": "2019-12-31", "period_start": "2019-12-31", "period_end": "2019-12-31", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": "26.00", "tangible_fixed_assets": "1010884.00", "debtors": "3515774.00", "cash_bank_in_hand": "762068.00", "current_assets": "4277842.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3734072.00", "total_assets_less_current_liabilities": "4744956.00", "net_assets_liabilities": "4607424.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2020.zip" }, { "url": "/company/04371441/accounts/2019-06-04", "pdf_url": "/company/04371441/accounts/2019-06-04.pdf", "made_up_date": "2019-06-04", "period_start": "2019-06-04", "period_end": "2019-06-04", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": "18.00", "tangible_fixed_assets": "879859.00", "debtors": "1707211.00", "cash_bank_in_hand": "1427067.00", "current_assets": "3134278.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2574076.00", "total_assets_less_current_liabilities": "3453935.00", "net_assets_liabilities": "3338166.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2020.zip" }, { "url": "/company/04371441/accounts/2018-09-30", "pdf_url": "/company/04371441/accounts/2018-09-30.pdf", "made_up_date": "2018-09-30", "period_start": "2018-09-30", "period_end": "2018-09-30", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "709292.00", "debtors": "1413957.00", "cash_bank_in_hand": "392694.00", "current_assets": "1806651.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1246466.00", "total_assets_less_current_liabilities": "1955758.00", "net_assets_liabilities": "1873679.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2019.zip" }, { "url": "/company/04371441/accounts/2017-09-30", "pdf_url": "/company/04371441/accounts/2017-09-30.pdf", "made_up_date": "2017-09-30", "period_start": "2017-09-30", "period_end": "2017-09-30", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "723579.00", "debtors": "356398.00", "cash_bank_in_hand": "609276.00", "current_assets": "965674.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "908506.00", "total_assets_less_current_liabilities": "1632085.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "10.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2018.zip" }, { "url": "/company/04371441/accounts/2016-09-30", "pdf_url": "/company/04371441/accounts/2016-09-30.pdf", "made_up_date": "2016-09-30", "period_start": "2015-10-01", "period_end": "2016-09-30", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "645754.00", "debtors": "447474.00", "cash_bank_in_hand": "478177.00", "current_assets": "925651.00", "creditors_due_within_one_year": "203377.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "722274.00", "total_assets_less_current_liabilities": "1368028.00", "net_assets_liabilities": null, "called_up_share_capital": "10.00", "profit_loss_account_reserve": "1368018.00", "shareholder_funds": "1368028.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "652993.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2017.zip" }, { "url": "/company/04371441/accounts/2015-09-30", "pdf_url": "/company/04371441/accounts/2015-09-30.pdf", "made_up_date": "2015-09-30", "period_start": "2015-09-30", "period_end": "2015-09-30", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "643169.00", "debtors": "191152.00", "cash_bank_in_hand": "243432.00", "current_assets": "434584.00", "creditors_due_within_one_year": "78993.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "355591.00", "total_assets_less_current_liabilities": "998760.00", "net_assets_liabilities": "998760.00", "called_up_share_capital": "10.00", "profit_loss_account_reserve": "998750.00", "shareholder_funds": "998760.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2016.zip" }, { "url": "/company/04371441/accounts/2014-09-30", "pdf_url": "/company/04371441/accounts/2014-09-30.pdf", "made_up_date": "2014-09-30", "period_start": "2014-09-30", "period_end": "2014-09-30", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "498690.00", "debtors": null, "cash_bank_in_hand": "154486.00", "current_assets": "154486.00", "creditors_due_within_one_year": "99368.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "55118.00", "total_assets_less_current_liabilities": "553808.00", "net_assets_liabilities": null, "called_up_share_capital": "10.00", "profit_loss_account_reserve": "553798.00", "shareholder_funds": "553808.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2015.zip" }, { "url": "/company/04371441/accounts/2013-09-30", "pdf_url": "/company/04371441/accounts/2013-09-30.pdf", "made_up_date": "2013-09-30", "period_start": "2013-09-30", "period_end": "2013-09-30", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "243835.00", "debtors": "124115.00", "cash_bank_in_hand": "192656.00", "current_assets": "316771.00", "creditors_due_within_one_year": "128885.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "187886.00", "total_assets_less_current_liabilities": "431721.00", "net_assets_liabilities": "431721.00", "called_up_share_capital": "10.00", "profit_loss_account_reserve": "431711.00", "shareholder_funds": "431721.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2014.zip" }, { "url": "/company/04371441/accounts/2012-09-30", "pdf_url": "/company/04371441/accounts/2012-09-30.pdf", "made_up_date": "2012-09-30", "period_start": "2012-09-30", "period_end": "2012-09-30", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "192562.00", "debtors": null, "cash_bank_in_hand": "359341.00", "current_assets": "359341.00", "creditors_due_within_one_year": "179828.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "179513.00", "total_assets_less_current_liabilities": "372075.00", "net_assets_liabilities": "372075.00", "called_up_share_capital": "10.00", "profit_loss_account_reserve": "372065.00", "shareholder_funds": "372075.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2013.zip" }, { "url": "/company/04371441/accounts/2011-09-30", "pdf_url": "/company/04371441/accounts/2011-09-30.pdf", "made_up_date": "2011-09-30", "period_start": "2011-09-30", "period_end": "2011-09-30", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "75529.00", "debtors": null, "cash_bank_in_hand": "145829.00", "current_assets": "145829.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "41336.00", "total_assets_less_current_liabilities": "116865.00", "net_assets_liabilities": "116865.00", "called_up_share_capital": "10.00", "profit_loss_account_reserve": "116855.00", "shareholder_funds": "116865.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2012.zip" }, { "url": "/company/04371441/accounts/2010-09-30", "pdf_url": "/company/04371441/accounts/2010-09-30.pdf", "made_up_date": "2010-09-30", "period_start": "2010-09-30", "period_end": "2010-09-30", "entity_name": "Nanopharm Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "83572.00", "debtors": "29610.00", "cash_bank_in_hand": "204660.00", "current_assets": "234270.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "185577.00", "total_assets_less_current_liabilities": "269149.00", "net_assets_liabilities": "269149.00", "called_up_share_capital": "10.00", "profit_loss_account_reserve": "269139.00", "shareholder_funds": "269149.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2011.zip" } ], "pdf_only_filings": [ { "made_up_date": "2022-12-31", "filing_date": "2023-09-29", "form_type": "AA", "description": "accounts-with-accounts-type-small", "paper_filed": null, "pdf_url": "/company/04371441/accounts/2022-12-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04371441/filing-history/MzM5NDg4NDQ1NmFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2009-09-30", "filing_date": "2010-04-06", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04371441/accounts/2009-09-30.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04371441/filing-history/MzAxMjg4OTE2M2FkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2008-09-30", "filing_date": "2009-01-23", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04371441/accounts/2008-09-30.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04371441/filing-history/MjAyNDA0MzU2OWFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2008-02-29", "filing_date": "2008-12-21", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04371441/accounts/2008-02-29.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04371441/filing-history/MjAyMDk5OTQ5NGFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2007-02-28", "filing_date": "2007-12-27", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": null, "pdf_url": "/company/04371441/accounts/2007-02-28.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04371441/filing-history/MTkwMTczOTU4YWRpcXprY3g/document?format=pdf&download=0" }, { "made_up_date": "2006-02-28", "filing_date": "2007-02-08", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04371441/accounts/2006-02-28.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04371441/filing-history/MTc1NzgwMjM0YWRpcXprY3g/document?format=pdf&download=0" }, { "made_up_date": "2005-02-28", "filing_date": "2006-05-22", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04371441/accounts/2005-02-28.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04371441/filing-history/MTYwNzc0MTE3YWRpcXprY3g/document?format=pdf&download=0" }, { "made_up_date": "2004-02-29", "filing_date": "2005-03-04", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04371441/accounts/2004-02-29.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04371441/filing-history/MzY4MzQ3MTNhZGlxemtjeA/document?format=pdf&download=0" }, { "made_up_date": "2003-02-28", "filing_date": "2003-12-12", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04371441/accounts/2003-02-28.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04371441/filing-history/NDA2NjgwOTVhZGlxemtjeA/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/04371441/filing-history" }, "confirmation_statement": { "next_due": "2026-12-30", "last_made_up": "2025-12-16" }, "officers": [], "psc": [ { "name": "Mr Mark Rowland Clement", "kind": "individual-person-with-significant-control", "person_url": "/person/3150999", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2016-04-06", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Dr Jagdeep Singh Shur", "kind": "individual-person-with-significant-control", "person_url": "/person/2084722", "controlling_company_url": null, "natures_of_control": [ "right-to-appoint-and-remove-directors" ], "notified_on": "2016-04-06", "ceased_on": "2019-06-05", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Prof Robert Price", "kind": "individual-person-with-significant-control", "person_url": "/person/4269583", "controlling_company_url": null, "natures_of_control": [ "right-to-appoint-and-remove-directors" ], "notified_on": "2016-04-06", "ceased_on": "2019-06-05", "nationality": "British", "country_of_residence": "Wales", "source": "snapshot" }, { "name": "Sbms Enterprises Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent-as-firm", "voting-rights-25-to-50-percent-as-firm" ], "notified_on": "2016-04-06", "ceased_on": "2019-06-05", "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Silures Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-50-to-75-percent-as-firm", "voting-rights-50-to-75-percent-as-firm", "right-to-appoint-and-remove-directors-as-firm" ], "notified_on": "2016-04-06", "ceased_on": "2019-06-05", "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Aptargroup Uk Holdings Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/04613135", "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2019-06-05", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-09T05:54:12.415413+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }